Related references
Note: Only part of the references are listed.Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice
Ngoc Nguyen et al.
CARDIOVASCULAR PATHOLOGY (2013)
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE(-/-) Mice
Naim Panjwani et al.
ENDOCRINOLOGY (2013)
Diabetic atherosclerosis in APOE☆4 mice: synergy between lipoprotein metabolism and vascular inflammation
Lance A. Johnson et al.
JOURNAL OF LIPID RESEARCH (2013)
New ascending aortic aneurysm model in rats reproduces main structural features of degenerative ascending thoracic aortic aneurysms in human beings
Narcis Costin Radu et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
Michishige Terasaki et al.
PLOS ONE (2013)
Coronary Flow Reserve from Mouse to Man-from Mechanistic Understanding to Future Interventions
Li-Ming Gan et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2013)
Accelerated Atherosclerosis in Apoe-/- Mice Heterozygous for the Insulin Receptor and the Insulin Receptor Substrate-1
Elena V. Galkina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Relationship between hemodynamics and atherosclerosis in aortic arches of apolipoprotein E-null mice on 129S6/SvEvTac and C57BL/6J genetic backgrounds
Hirofumi Tomita et al.
ATHEROSCLEROSIS (2012)
Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis
K. Toyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights
Rishi Puri et al.
CURRENT DIABETES REPORTS (2012)
Sitagliptin promotes macrophage-to-faeces reverse cholesterol transport through reduced intestinal cholesterol absorption in obese insulin resistant CETP-apoB100 transgenic mice
F. Briand et al.
DIABETES OBESITY & METABOLISM (2012)
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe -/- mice
F. Vittone et al.
DIABETOLOGIA (2012)
New Experimental Models of Diabetic Nephropathy in Mice Models of Type 2 Diabetes: Efforts to Replicate Human Nephropathy
Maria Jose Soler et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Insulin Resistance Promotes Early Atherosclerosis via Increased Proinflammatory Proteins and Oxidative Stress in Fructose-Fed ApoE-KO Mice
Beatriz Cannizzo et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr-/- Mice Compared to Nondiabetic LDLr-/- Mice
Daniel Engelbertsen et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Coronary artery wall imaging in mice using osmium tetroxide and micro-computed tomography (micro-CT)
Vinay M. Pai et al.
JOURNAL OF ANATOMY (2012)
A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice
Junichi Matsubara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Impaired Myogenic Tone in Isolated Cerebral and Coronary Resistance Arteries from the Goto-Kakizaki Rat Model of Type 2 Diabetes
H. Kold-Petersen et al.
JOURNAL OF VASCULAR RESEARCH (2012)
Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice
Michishige Terasaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Ultrasound Biomicroscopy for Longitudinal Studies of Carotid Plaque Development in Mice: Validation with Histological Endpoints
Erin Y. Harmon et al.
PLOS ONE (2012)
Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice
Yukinori Nogi et al.
PLOS ONE (2012)
Spontaneously diabetic Ins2+/Akita: apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis
John Y. Jun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Human Aldose Reductase Expression Accelerates Atherosclerosis in Diabetic Apolipoprotein E-/- Mice
Srinivasan Vedantham et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness
Paige S. Katz et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA-cp rat model of the metabolic syndrome
Jing Lu et al.
BRITISH JOURNAL OF NUTRITION (2011)
Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
Suvi E. Heinonen et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
Jing Li et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Karin E. Bornfeldt et al.
CELL METABOLISM (2011)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice
Zhonglin Xie et al.
DIABETES (2011)
Critical role of chemokine (C-C motif) receptor 2 (CCR2) in the KKAy + Apoe -/- mouse model of the metabolic syndrome
H. G. Martinez et al.
DIABETOLOGIA (2011)
TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe-/- mice
B. A. Di Bartolo et al.
DIABETOLOGIA (2011)
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
M. Nagashima et al.
DIABETOLOGIA (2011)
The Fat-Fed Apolipoprotein E Knockout Mouse Brachiocephalic Artery in the Study of Atherosclerotic Plaque Rupture
Andrew R. Bond et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E-Deficient Mice
Nga N. Ta et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Renal Podocyte Apoptosis in Zucker Diabetic Fatty Rats: Involvement of Methylglyoxal-Induced Oxidative DNA Damage
J. Kim et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2011)
Hyperglycemic Ins2AkitaLdlr-/- mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease
Changcheng Zhou et al.
JOURNAL OF LIPID RESEARCH (2011)
Nifedipine Induces Peroxisome Proliferator-Activated Receptor-γ Activation in Macrophages and Suppresses the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
Norio Ishii et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention
Maria Luisa Balestrieri et al.
ATHEROSCLEROSIS (2010)
Model of intestinal chylomicron over-production and Ezetimibe treatment: Impact on the retention of cholesterol in arterial vessels
R. Mangat et al.
ATHEROSCLEROSIS SUPPLEMENTS (2010)
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
Masayuki Arakawa et al.
DIABETES (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
A Murine Model of Obesity With Accelerated Atherosclerosis
Victoria L. King et al.
OBESITY (2010)
Can Animal Models of Disease Reliably Inform Human Studies?
H. Bart van der Worp et al.
PLOS MEDICINE (2010)
Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function
Ratnadeep Basu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Antidiabetic effects of 11β-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis
D. J. Lloyd et al.
DIABETES OBESITY & METABOLISM (2009)
Early atherosclerosis and vascular inflammation in mice with diet-induced type 2 diabetes
E. D. Bartels et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Roles of matrix metalloproteinases in flow-induced outward vascular remodeling
Ryo Ota et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Differential Effects of Diet-Induced Dyslipidemia and Hyperglycemia on Mesenteric Resistance Artery Structure and Function in Type 2 Diabetes
Kamakshi Sachidanandam et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta
Emi Kazuyama et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats
John Baynes et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2009)
Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome:: Apob48-/- Lepob/ob mice devoid of ApoE or Ldlr
David J. Lloyd et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis
J. Gronros et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Molecular Mechanisms of Atherosclerosis in Metabolic Syndrome Role of Reduced IRS2-Dependent Signaling
Herminia Gonzalez-Navarro et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Severe coronary artery stenoses and reduced coronary flow velocity reserve in atherosclerotic mouse model Doppler echocardiography validation study
Antti Saraste et al.
ATHEROSCLEROSIS (2008)
Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetes
Geanina Onuta et al.
MICROVASCULAR RESEARCH (2008)
Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and Hypercholesterolemia
Suvi E. Heinonen et al.
CIRCULATION RESEARCH (2007)
Coronary artery disease progression is associated with increased resistance of hearts and myocytes to cardiac insults
Anabelle Chase et al.
CRITICAL CARE MEDICINE (2007)
Mouse models for atherosclerosis and pharmaceutical modifiers
Susanne Zadelaar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice
Kimberly R. Coenen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis
Susan A. Marsh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Recipes for creating animal models of diabetic cardiovascular disease
Willa Hsueh et al.
CIRCULATION RESEARCH (2007)
Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice
Paul Lewis et al.
CIRCULATION (2007)
Diabetic atherosclerosis mouse models
Kenneth K. Wu et al.
ATHEROSCLEROSIS (2007)
Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice
Herminia Gonzalez-Navarro et al.
FRONTIERS IN BIOSCIENCE (2007)
Dual PPARα/γ agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE*3Leiden mice
A. Susanne M. Zadelaar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE* 3-Leiden mice
Marit Westerterp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice
Vincent van Weel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors
M Kakoki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Proximal to middle left coronary artery flow velocity ratio, as assessed using color Doppler echocardiography, predicts coronary artery atherosclerosis in mice
J Grönros et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice
ML Gruen et al.
ATHEROSCLEROSIS (2006)
Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis
J Baumgartl et al.
CELL METABOLISM (2006)
Diabetic cardiomyopathy - The search for a unifying hypothesis
IG Poornima et al.
CIRCULATION RESEARCH (2006)
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
T Wendt et al.
ATHEROSCLEROSIS (2006)
Impact of genetic background on nephropathy in diabetic mice
SB Gurley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy
K Susztak et al.
DIABETES (2006)
A mouse model for human atherosclerosis: Long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E-0) mice
Raymond Coleman et al.
ACTA HISTOCHEMICA (2006)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects
AC Calkin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
RK Vikramadithyan et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Functional and morphologic imaging of coronary atherosclerosis in living mice using high-resolution color doppler echocardiography and ultrasound biomicroscopy
J Wikström et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor
KK Wu et al.
ATHEROSCLEROSIS (2005)
Increased tolerance to hypoxic metabolic inhibition and reoxygenation of cardiomyocytes from apolipoprotein E-deficient mice
M Dworschak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
The Ins2Akita mouse as a model of early retinal complications in diabetes
AJ Barber et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E
MH Clough et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice
C Choeiri et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions
CB Renard et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications
ZY Fang et al.
ENDOCRINE REVIEWS (2004)
Preliminary report - Cardiac dysfunction in the euglycemic diabetic-prone BB Wor rat
TL Broderick et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Site specificity of atherosclerosis - Site-selective responses to atherosclerotic modulators
PA VanderLaan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes
JW Phillips et al.
CIRCULATION (2003)
Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity
SA Schreyer et al.
ATHEROSCLEROSIS (2003)
Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats
S Schafer et al.
CARDIOVASCULAR RESEARCH (2003)
Nephropathy in a hypercholesterolemic mouse model with streptozotocin-induced diabetes
SM Hammad et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2003)
Diurnal heart rate reactivity: a predictor of severity of experimental coronary and carotid atherosclerosis
HS Bassiouny et al.
JOURNAL OF CARDIOVASCULAR RISK (2002)
Complications of IgA nephropathy in a non-insulin-dependent diabetes model, the Akita mouse
T Haseyama et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Diameters of the thoracic aorta throughout life as measured with helical computed tomography
A Hager et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2002)
Control of cholesterol turnover in the mouse
JM Dietschy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes
P Pacher et al.
DIABETES (2002)
Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice
LV d'Uscio et al.
STROKE (2001)
Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor
AH Hasty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice
F Calara et al.
JOURNAL OF PATHOLOGY (2001)
Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice
PJ Kuhlencordt et al.
CIRCULATION (2001)
Preconditioning protects the severely atherosclerotic mouse heart
GH Li et al.
ANNALS OF THORACIC SURGERY (2001)
Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100
MM Véniant et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse
P Cristofori et al.
JOURNAL OF HYPERTENSION (2000)
Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice - Establishment of a combined model and association with heat shock protein 65 immunity
P Keren et al.
DIABETES (2000)
Apolipoprotein E and atherosclerosis
LK Curtiss et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
Share Paper
